<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2565-005X</journal-id>
<journal-title><![CDATA[Gaceta mexicana de oncología]]></journal-title>
<abbrev-journal-title><![CDATA[Gac. mex. oncol.]]></abbrev-journal-title>
<issn>2565-005X</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Oncología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2565-005X2021000100004</article-id>
<article-id pub-id-type="doi">10.24875/j.gamo.200000311</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Análisis dosimétrico entre puntos «A» de Mánchester y volumen blanco clínico de alto riesgo en braquiterapia 3D guiada por imagen para el cáncer cervicouterino]]></article-title>
<article-title xml:lang="en"><![CDATA[Dosimetric analysis between Mánchester points “A” and high-risk clinical target volume in the three-dimensional image-guided branchytherapy for uterine cervical cancer]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Chacón-Anaya]]></surname>
<given-names><![CDATA[Silvia C.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Durán-Cruz]]></surname>
<given-names><![CDATA[Mauricio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Reding-Bernal]]></surname>
<given-names><![CDATA[Arturo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barragán-Pérez]]></surname>
<given-names><![CDATA[José A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Secretaría de Salud Hospital General de México Servicio de Radiooncología]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2021</year>
</pub-date>
<volume>20</volume>
<numero>1</numero>
<fpage>4</fpage>
<lpage>11</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2565-005X2021000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2565-005X2021000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2565-005X2021000100004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: La braquiterapia ginecológica ha evolucionado desde el concepto de prescripción puntual (Mánchester) a volúmenes de tratamiento.  Objetivo: Analizar el resultado dosimétrico entre la prescripción a puntos A y volumen blanco clínico de alto riesgo (CTV-HR).  Métodos: Se realizaron ambas planeaciones en 28 pacientes con cáncer cervicouterino estadio IB2-IVA (112 aplicaciones), la dosis utilizada fue cuatro fracciones de 5.62 Gy  Resultados: La dosis media al 90% del CTV-HR y desviación estándar: 92.1 ± 2.7 Gy fue más baja (p &lt; 0.008) que a puntos A (103.4 ± 21.6 Gy). La cobertura al CTV-HR: 97.8 ± 7.3% fue mayor (p &lt; 0.000000000043) que con puntos A (86.6 ± 14.7%). La D2 cc de vejiga fue: 83.8 ± 22.4 Gy vs. punto vejiga ICRU 38 (66.1 ± 7.6 Gy) (p &lt; 0.0057), demostrando la subestimación de la dosis en la planeación puntual. La D2 cc de recto fue: 73.6 ± 12.7 Gy vs. punto recto ICRU 38 (75.1 ± 11.9 Gy) (p &lt; 0.4857), no difiriendo significativamente.  Conclusiones: La braquiterapia 3D proporciona una mayor cobertura de dosis al CTV-HR comparándolo con el sistema tradicional, existiendo una subestimación de la dosis recibida en vejiga en el sistema puntual.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Background: Gynecological brachytherapy has evolved from the concept of punctual prescription (Manchester) to treatment volumes.  Objective: To analyze the dosimetric result between the prescription at point A and high-risk clinical target volume (HR-CTV).  Methods: Both plans were performed in 28 patients with stage IB2-IVA cervical cancer (112 applications), the dose used was 4 fractions of 5.62 Gy.  Results: The mean D90 (dose to 90% volume) and its standard deviation for HR-CTV: 92.1 ± 2.7 Gy, was lower (p &lt; 0.008) than at points A (103.4 ± 21.6 Gy). HR-CTV coverage: 97.8 ± 7.3% was higher (p &lt; 0.000000000043) than with points A (86.6 ± 14.7%). The bladder D2 cc was: 83.8 ± 22.4 Gy vs. ICRU 38 bladder point (66.1 ± 7.6 Gy) (p &lt; 0.0057), demonstrating the underestimation of the dose in the punctual planning. The D2 cc of the rectum was: 73.6 ± 12.7 Gy vs. ICRU 38 straight point (75.1 ± 11.9 Gy) (p &lt; 0.4857), not differing significantly.  Conclusions: 3D brachytherapy provides greater dose coverage for HR-CTV compared to the traditional system, with an underestimation of the dose received in the bladder in the punctual system.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Cervicouterino]]></kwd>
<kwd lng="es"><![CDATA[Braquiterapia intracavitaria]]></kwd>
<kwd lng="es"><![CDATA[Mánchester]]></kwd>
<kwd lng="es"><![CDATA[Volumétrica]]></kwd>
<kwd lng="en"><![CDATA[Cervical cancer]]></kwd>
<kwd lng="en"><![CDATA[Brachytherapy]]></kwd>
<kwd lng="en"><![CDATA[Intracavitary]]></kwd>
<kwd lng="en"><![CDATA[Manchester]]></kwd>
<kwd lng="en"><![CDATA[Volumetric]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bray]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ferlay]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Soerjomataran]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Siegel]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Torre]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Jemal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global Cancer Statistics 2018:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries]]></article-title>
<source><![CDATA[CA Cancer J Clin]]></source>
<year>2018</year>
<volume>68</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>394-424</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mayadev]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Viswanathan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[Albuquerque]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Damato]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[American Brachytherapy Task Group Report:A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer]]></article-title>
<source><![CDATA[Brachytherapy]]></source>
<year>2017</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>22-43</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Georg]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Dimopoulos]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Dorr]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Sturdza]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Berger]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy]]></article-title>
<source><![CDATA[Int J Radiat Oncol Biol Phys]]></source>
<year>2011</year>
<volume>79</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>356-62</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Potter]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Georg]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Dimopoulos]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Grimm]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Berger]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Nesvacil]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer]]></article-title>
<source><![CDATA[Radiother Oncol]]></source>
<year>2011</year>
<volume>100</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>116-23</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tod]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Meredith]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A dosage system for use in the treatment of cancer of the uterine cervix]]></article-title>
<source><![CDATA[Br J Radio]]></source>
<year>1938</year>
<volume>11</volume>
<page-range>809</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fletcher]]></surname>
<given-names><![CDATA[GH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cervical radium applicators with screening in the direction of bladder and rectum]]></article-title>
<source><![CDATA[Radiology]]></source>
<year>1953</year>
<volume>60</volume>
<page-range>77-84</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nag]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Erickson]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Thomadsen]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Orton]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Demanes]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Petereit]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The American brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix]]></article-title>
<source><![CDATA[Int J Radiat Oncol Biol Phys]]></source>
<year>2000</year>
<volume>48</volume>
<page-range>201-11</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viswanathan]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
<name>
<surname><![CDATA[Thomadsen]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[American Brachytherapy Society Cervical Cancer recommendations Committee;American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I:General principles]]></article-title>
<source><![CDATA[Brachytherapy]]></source>
<year>2012</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>33-46</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haie-Meder]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Potter]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[van Limbergen]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Briot]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[de Brabandere]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dimopoulos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I):concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV]]></article-title>
<source><![CDATA[Radiother Oncol]]></source>
<year>2005</year>
<volume>74</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>235-45</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Potter]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Haie-Meder]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[van Limbergen]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Barillot]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[de Brabandere]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dimopoulos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (II):concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology]]></article-title>
<source><![CDATA[Radiother Oncol]]></source>
<year>2006</year>
<volume>78</volume>
<page-range>67-77</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wyckoff]]></surname>
<given-names><![CDATA[HO]]></given-names>
</name>
<name>
<surname><![CDATA[Allisy]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Caswell]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Adams]]></surname>
<given-names><![CDATA[ED]]></given-names>
</name>
<name>
<surname><![CDATA[Cowper]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Edholm]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[International Commission on Radiation Units and Measurements]]></article-title>
<source><![CDATA[ICRU REPORT 38. Dose and Volume Specification for reporting Intracavitary Therapy in Gynecology]]></source>
<year>1985</year>
<publisher-loc><![CDATA[Bethesda, Maryland, EE.UU ]]></publisher-loc>
<publisher-name><![CDATA[International Commission on Radiation Units &amp;Measurements]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eskander]]></surname>
<given-names><![CDATA[RN]]></given-names>
</name>
<name>
<surname><![CDATA[Scanderbeg]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Saenz]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Yashar]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring]]></article-title>
<source><![CDATA[Int J Gynecol Cancer]]></source>
<year>2010</year>
<volume>20</volume>
<page-range>47Y53</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dimopoulos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kirisits]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fidarova]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Berger]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Georg]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dose volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy]]></article-title>
<source><![CDATA[Int J Radiat Oncol Biol Phys]]></source>
<year>2009</year>
<volume>75</volume>
<page-range>56-63</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kirisits]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Po?tter]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Dimopoulos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wachter-Gerstner]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Georg]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dose and volume parameters for MRI based treatment planning in intracavitary brachytherapy of cervix cancer]]></article-title>
<source><![CDATA[Int J Radiat Oncol Biol Phys]]></source>
<year>2005</year>
<volume>62</volume>
<page-range>901-11</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Derks]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Steenhuijsen]]></surname>
<given-names><![CDATA[JLG]]></given-names>
</name>
<name>
<surname><![CDATA[van den Berg]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[Houterman]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cnossen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Haaren]]></surname>
<given-names><![CDATA[PV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of brachytherapy technique (2D vs. 3D) on outcome following radiotherapy of cervical cancer]]></article-title>
<source><![CDATA[J Contemp Brachytherapy]]></source>
<year>2018</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>17-25</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ha]]></surname>
<given-names><![CDATA[IB]]></given-names>
</name>
<name>
<surname><![CDATA[Jeong]]></surname>
<given-names><![CDATA[BK]]></given-names>
</name>
<name>
<surname><![CDATA[Kang]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Jeon]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[YH]]></given-names>
</name>
<name>
<surname><![CDATA[Choi]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Who really benefits from 3D-based planning of brachytherapy for cervical cancer?]]></article-title>
<source><![CDATA[J Korean Med Sci]]></source>
<year>2018</year>
<volume>33</volume>
<numero>18</numero>
<issue>18</issue>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[RY]]></given-names>
</name>
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Duan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix:Dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel]]></article-title>
<source><![CDATA[Brachytherapy]]></source>
<year>2007</year>
<volume>6</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>187-94</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
